# AMARIN CORP PLC\UK

AMARIN CORP PLC\UK is a public company listed on Nasdaq as AMRN, headquartered in Dublin 2, Ireland.

## Company overview

- **Legal name:** AMARIN CORP PLC\UK
- **Former names in filing history:** AMARIN CORP PLC\UK (2001-12-17 to 2026-08-27); AMARIN PHARMACEUTICALS PLC (2000-07-13 to 2000-07-13); ETHICAL HOLDINGS PLC (1998-10-21 to 1998-01-28)
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Dublin 2, Ireland
- **Incorporated in:** X0
- **Fiscal year end:** December 31
- **Ticker:** Nasdaq: AMRN
- **SEC CIK:** 0000897448

## About

AMARIN CORP PLC\UK is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000897448, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-02, it reported annual revenue of USD 213,646,000; net income of USD -38,798,000; total assets of USD 670,775,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $213.6M (USD 213,646,000)
- **Net income:** -$38.8M (USD -38,798,000)
- **Total assets:** $670.8M (USD 670,775,000)
- **Cash and equivalents:** $134.7M (USD 134,660,000)
- **Operating cash flow:** $6.7M (USD 6,728,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $228.6M (USD 228,614,000)
- **Net income:** -$82.2M (USD -82,183,000)
- **Total assets:** $685.3M (USD 685,349,000)
- **Cash and equivalents:** $121.0M (USD 121,038,000)
- **Operating cash flow:** -$31.0M (USD -31,020,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $306.9M (USD 306,911,000)
- **Net income:** -$59.1M (USD -59,112,000)
- **Total assets:** $831.7M (USD 831,684,000)
- **Cash and equivalents:** $199.3M (USD 199,252,000)
- **Operating cash flow:** $6.9M (USD 6,880,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $369.2M (USD 369,193,000)
- **Net income:** -$105.8M (USD -105,803,000)
- **Total assets:** $886.2M (USD 886,179,000)
- **Cash and equivalents:** $217.7M (USD 217,666,000)
- **Operating cash flow:** -$180.1M (USD -180,092,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 10-Q — filed 2026-07-29 — period 2026-06-30 — 10-Q
- Form 8-K — filed 2026-07-29 — period 2026-07-29 — 8-K
- Form 8-K — filed 2026-05-15 — period 2026-05-13 — 8-K
- Form 10-Q — filed 2026-04-29 — period 2026-03-31 — 10-Q
- Form 8-K — filed 2026-04-29 — period 2026-04-29 — 8-K
- Form DEF 14A — filed 2026-04-10 — period 2026-04-10 — DEF 14A
- Form 8-K — filed 2026-03-27 — period 2026-03-25 — 8-K
- Form 10-K — filed 2026-03-02 — period 2025-12-31 — 10-K
- Form 8-K — filed 2026-02-25 — period 2026-02-25 — 8-K
- Form 8-K — filed 2026-01-08 — period 2026-01-08 — 8-K
- Form 10-Q — filed 2025-10-29 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-10-29 — period 2025-10-29 — 8-K

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/amarin-corp-plc-uk

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology